XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2023
May 11, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity File Number 001-37942  
Entity Registrant Name DIFFUSION PHARMACEUTICALS INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 30-0645032  
Entity Address, Address Line One 300 East Main Street, Suite 201  
Entity Address, City or Town Charlottesville  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 22902  
City Area Code 434  
Local Phone Number 220-0718  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol DFFN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   2,040,025
Entity Central Index Key 0001053691  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false